Thrombin Generation and Fibrinolysis in Colorectal Cancer Metastases
Author Information
Author(s): Mikkel Lundbech, Andreas Engel Krag, Lene Hjerrild Iversen, Birgitte Brandsborg, Anne-Mette Hvas
Primary Institution: Aarhus University Hospital
Hypothesis
The study investigates the association between the burden of peritoneal metastases from colorectal cancer and biomarkers reflecting thrombin generation and fibrinolysis.
Conclusion
Increased peritoneal metastatic burden from colorectal cancer does not seem to affect thrombin generation and fibrinolysis.
Supporting Evidence
- Patients with extensive PM-CRC had lower thrombin generation markers than those with limited PM-CRC.
- Non-significant differences in fibrinolysis were observed between the two groups.
- All patients had comparable comorbidities and administration of neoadjuvant chemotherapy.
Takeaway
The study looked at patients with colorectal cancer and found that having more cancer in the belly doesn't change how their blood clots or breaks down.
Methodology
A cohort of 55 patients with PM-CRC was studied, measuring thrombin generation and fibrinolysis biomarkers before surgery.
Potential Biases
Potential overestimation of PM-CRC due to similarities with benign lesions.
Limitations
The small sample size of the extensive PM-CRC group may have led to a lack of statistical power.
Participant Demographics
Patients included had comparable mean age, sex, and body mass index.
Statistical Information
P-Value
p=0.72 for F1+2, p=0.32 for TAT, p=0.19 for ETP
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website